RELENZA

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Ecuador, Estonia, Finland, Hong Kong SAR China, Ireland, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug RELENZA contains one active pharmaceutical ingredient (API):

1	Zanamivir UNII L6O3XI777I - ZANAMIVIR
	Zanamivir is an inhibitor of influenza virus neuraminidase, an enzyme that releases viral particles from the plasma membrane of infected cells and promotes virus spread in the respiratory tract. The activity of zanamivir is extracellular. It reduces the propagation of both influenza A and B viruses by inhibiting the release of infectious influenza virions from the epithelial cells of the respiratory tract.
	Read more about Zanamivir

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RELENZA Inhalation powder, pre-dispensed	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AH01	Zanamivir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AH Neuraminidase inhibitors
Discover more medicines within J05AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510606401171310
CA	Health Products and Food Branch	02240863
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.405-12-06
EE	Ravimiamet	1040083, 1265565
ES	Centro de información online de medicamentos de la AEMPS	62712
FI	Lääkealan turvallisuus- ja kehittämiskeskus	495820
GB	Medicines & Healthcare Products Regulatory Agency	41256
HK	Department of Health Drug Office	45843
JP	医薬品医療機器総合機構	6250702G1028
LT	Valstybinė vaistų kontrolės tarnyba	1023715, 1025823
MT	Medicines Authority	MA192/03001
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	378M99
NL	Z-Index G-Standaard, PRK	66397
NZ	Medicines and Medical Devices Safety Authority	8410
PL	Rejestru Produktów Leczniczych	100178060
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65857001, W65857002
SG	Health Sciences Authority	11199P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522550180
US	FDA, National Drug Code	0173-0681
ZA	Health Products Regulatory Authority	34/20.2.8/0032